Lexeo Therapeutics
lexeotx.com
Actively hiring
Cell & Gene Therapy
Pharmaceuticals
Health Care
As featured in
View 1 job
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
News
Lexeo Therapeutics advances gene therapy and gains RMAT status
Detailed price information for Lexeo Therapeutics Inc (LXEO-Q) from The Globe and Mail including charting and trades.
Read more
Report
Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia
Detailed price information for Lexeo Therapeutics Inc (LXEO-Q) from The Globe and Mail including charting and trades.
Read more
Report
Wall Street Rallies Behind Lexeo Therapeutics (LXEO)'s Gene Therapy Pipeline
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Lexeo Therapeutics, Inc. (NASDAQ:LXEO) is a consensus buy from all eleven analysts covering the stock. While the target price ranges from $1
Read more
Report
Pro access
Upgrade to see all 11 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Technologies
AI/ML
Feature Store
Interpretability
Multimodal AI
XGBoost
Machine Learning
Stack modernity
72/100
How modern this stack is, based on technology relevance, AI adoption and the share of legacy tools.
In-demand technologies
XGBoost
1 job
Required
$332k
+81% vs market
Multimodal AI
1 job
Required
$332k
+30% vs market
Feature Store
1 job
Optional
$332k
+48% vs market
Interpretability
1 job
Required
$332k
-9% vs market
Salary medians are calculated from this company's open jobs and compared with the market.
Industry adoption
Machine Learning
4%
Multimodal AI
2%
Feature Store
1%
Share of companies in the same industry that use each technology.
Stack changes
Machine Learning
Sep 2026
XGBoost
Sep 2026
Multimodal AI
Sep 2026
Interpretability
Sep 2026
Feature Store
Sep 2026
Technologies recently added to or removed from this company's stack - a signal of tech migrations and new initiatives.
Mastercard
General Dynamics Information Technology
Citi
Jobgether
HP Inc.
JPMorganChase
Salary insights
Compensation ranges based on this company's open jobs
Median
$172k
Typical range
$139k – $332k
Open positions
5
5
Jobs
Middle
20%
Senior
60%
Architect
20%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Middle | 1 | $139k | $139k |
| Senior | 3 | $172k | $154k – $332k |
| Architect | 1 | $207k | $207k |
Highest paying role
Senior Director, AI and Data Science (Drug Discovery and R&D Enablement)
$332k
Normalized to USD per year
Growth
Hiring Momentum
79/100
Scaling fast
Open positions
5
3 opened / 1 closed in 30 days
Median time-to-fill
57 days
faster than 28% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
60% ▲
Public Policy
20% ▲
Industrial Engineering
20% ▼
Activity Timeline
Added Machine Learning to stack
Sep 2026
Added XGBoost to stack
Sep 2026
Added Multimodal AI to stack
Sep 2026
Added Interpretability to stack
Sep 2026
Added Feature Store to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
1
Busiest office
New York
New York
United States
HQ
5 open roles 5 posted in 90 days 40% engineering 200-500 est. staff $201k Avg Salary
hires for Science & Research, Leadership, Public Policy
Park
United States
Regional office
345 Park Avenue South, 6th Floor,
Jobs
$230k – $332k per year • Remote/Hybrid • Full-Time • 10+ years exp • PhD • New York
XGBoost
Multimodal AI
Feature Store
Interpretability
Apply